{
    "Trade/Device Name(s)": [
        "Aptima Neisseria gonorrhoeae Assay"
    ],
    "Submitter Information": "Hologic, Inc.",
    "510(k) Number": "K231329",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063664"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL",
        "QEP"
    ],
    "Summary Letter Date": "December 28, 2023",
    "Summary Letter Received Date": "December 28, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3390"
    ],
    "Regulation Name(s)": [
        "Neisseria Spp. Direct Serological Test Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Neisseria gonorrhoeae ribosomal RNA (rRNA)"
    ],
    "Specimen Type(s)": [
        "Male urine"
    ],
    "Specimen Container(s)": [
        "Urine transport tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Panther system"
    ],
    "Method(s)/Technology(ies)": [
        "Target capture",
        "Transcription-mediated amplification (TMA)",
        "Hybridization protection assay (HPA)",
        "Nucleic acid amplification (NAAT)",
        "Chemiluminescent probe detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Target capture",
        "Chemiluminescent detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Aptima Neisseria gonorrhoeae Assay using NAAT for qualitative detection of Neisseria gonorrhoeae rRNA from male urine specimens on the Panther system",
    "Indications for Use Summary": "Qualitative nucleic acid amplification test to detect Neisseria gonorrhoeae ribosomal RNA in male urine specimens to aid diagnosis of gonococcal urogenital disease using the Panther system",
    "fda_folder": "Microbiology"
}